GlassScriptPhysician profile
Patricia Shustock
NPI 1326077157
$2,149.76
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,548 · 2020: $386 · 2021: $192 · 2022: $23.77.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,010.27 | 2019-2021 | |
| Coopervision INC. | $331.91 | 2019-2021 | |
| Alcon Vision LLC | $294.85 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $91.83 | 2019-2020 | |
| Maculogix, INC. | $90.60 | 2019 | |
| Visioneering Technologies, INC. | $85.24 | 2019 | |
| Kala Pharmaceuticals, INC. | $72.72 | 2021-2022 | |
| Sight Sciences, INC. | $72.63 | 2020-2021 | |
| Abb Con-Cise Optical Group LLC | $44.35 | 2019 | |
| Biotissue Holdings INC. | $27.22 | 2019 | |
| Sun Pharmaceutical Industries INC. | $17.90 | 2021 | |
| Oasis Medical, INC. | $10.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Shustock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.